Moecks, J., Soulières, D., & Klughammer, B. (2015). ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer. J Pathol Clin Res.
استشهاد بنمط شيكاغوMoecks, Joachim, Denis Soulières, و Barbara Klughammer. "ReadMax—a Novel Reading and Scoring Approach for EGFR Gene Copy Number to Predict Therapeutic Benefit of Erlotinib Treatment in EGFR Wild‐type Non‐small‐cell Lung Cancer." J Pathol Clin Res 2015.
MLA استشهادMoecks, Joachim, Denis Soulières, و Barbara Klughammer. "ReadMax—a Novel Reading and Scoring Approach for EGFR Gene Copy Number to Predict Therapeutic Benefit of Erlotinib Treatment in EGFR Wild‐type Non‐small‐cell Lung Cancer." J Pathol Clin Res 2015.